Form 4: Ingevity Corp Director Acquires Shares Through Deferred Stock Units

Director J. Kevin Willis acquired 570 shares of Ingevity Corp common stock through vested deferred stock units.

Summary

• J. Kevin Willis, a director at Ingevity Corp, acquired 570 shares of common stock on January 2, 2025.
• The shares were acquired through vested deferred stock units (DSUs) at a price of $39.54 per share.
• These DSUs were granted in lieu of quarterly director fees.
• The DSUs will convert to common stock upon the director's termination of board service.
• The transaction was reported on January 3, 2025.

Sentiment

Score: 7

Explanation: The transaction is a routine insider acquisition, which is generally viewed neutrally to slightly positive as it indicates director confidence. There is no negative information in the document.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The shares will be received upon the director's termination of board service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director compensation through deferred stock units is a common practice among publicly traded companies.
• The vesting and settlement terms are typical for such arrangements.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows director alignment with company performance.

Key Dates

Keywords

Ingevity Corp, Director, Stock Acquisition, Deferred Stock Units, DSUs, Insider Trading, SEC Form 4